Lili Fu

4.3k total citations · 3 hit papers
86 papers, 3.2k citations indexed

About

Lili Fu is a scholar working on Molecular Biology, Genetics and Nephrology. According to data from OpenAlex, Lili Fu has authored 86 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 21 papers in Genetics and 14 papers in Nephrology. Recurrent topics in Lili Fu's work include Genetic and Kidney Cyst Diseases (19 papers), Renal and related cancers (11 papers) and Biomedical Research and Pathophysiology (7 papers). Lili Fu is often cited by papers focused on Genetic and Kidney Cyst Diseases (19 papers), Renal and related cancers (11 papers) and Biomedical Research and Pathophysiology (7 papers). Lili Fu collaborates with scholars based in China, United States and Belgium. Lili Fu's co-authors include Changlin Mei, Xiang Gao, Xiangchen Gu, Bing Dai, Gaozhi Chen, Guang Liang, Xiaokun Li, Lijun Sun, Ming Wu and Moosa Mohammadi and has published in prestigious journals such as Nature, PLoS ONE and The FASEB Journal.

In The Last Decade

Lili Fu

81 papers receiving 3.2k citations

Hit Papers

Kruppel-Like Factor 15 Modulates Renal Interstitial Fibro... 2013 2026 2017 2021 2013 2017 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lili Fu China 25 1.5k 739 675 400 390 86 3.2k
Soji Kasayama Japan 38 1.4k 1.0× 525 0.7× 193 0.3× 284 0.7× 686 1.8× 140 4.7k
Kei Yamamoto Japan 28 1.4k 0.9× 202 0.3× 586 0.9× 447 1.1× 723 1.9× 66 3.3k
Yasumasa Ikeda Japan 34 970 0.7× 230 0.3× 228 0.3× 339 0.8× 342 0.9× 151 3.5k
Christian Rosenberger Germany 36 1.6k 1.1× 612 0.8× 1.6k 2.4× 1.7k 4.3× 622 1.6× 81 5.0k
Yabing Chen United States 26 1.2k 0.8× 354 0.5× 604 0.9× 401 1.0× 301 0.8× 54 2.6k
Julia Carracedo Spain 37 1.0k 0.7× 194 0.3× 981 1.5× 291 0.7× 434 1.1× 94 3.5k
Grazia Serino Italy 27 1.1k 0.7× 160 0.2× 460 0.7× 566 1.4× 225 0.6× 72 2.3k
Haiyan Fu China 30 1.3k 0.9× 240 0.3× 901 1.3× 328 0.8× 368 0.9× 105 2.9k
Farhad R. Danesh United States 31 2.4k 1.7× 233 0.3× 1.2k 1.8× 983 2.5× 564 1.4× 57 4.5k
Michael M. Hoffmann Germany 39 1.1k 0.7× 382 0.5× 198 0.3× 605 1.5× 1.4k 3.6× 143 4.5k

Countries citing papers authored by Lili Fu

Since Specialization
Citations

This map shows the geographic impact of Lili Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Fu more than expected).

Fields of papers citing papers by Lili Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Fu. The network helps show where Lili Fu may publish in the future.

Co-authorship network of co-authors of Lili Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Fu. A scholar is included among the top collaborators of Lili Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Fu. Lili Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Huang, Yan, Xiao Sun, Lili Fu, et al.. (2024). Evaluation of monoamine oxidase B fluctuation in liver fibrosis cell and mice models via a specificity fluorescent probe. Sensors and Actuators B Chemical. 417. 136111–136111. 6 indexed citations
4.
Yang, Ming, et al.. (2024). Inflammation Is More Sensitive than Cell Proliferation in Response to Rapamycin Treatment in Polycystic Kidney Disease. Kidney & Blood Pressure Research. 49(1). 60–68. 3 indexed citations
5.
Chen, Lingfeng, Lili Fu, Jingchuan Sun, et al.. (2023). Structural basis for FGF hormone signalling. Nature. 618(7966). 862–870. 68 indexed citations
6.
Du, Wen, Lili Fu, Yuting Guan, et al.. (2023). Activation of GPER1 in macrophages ameliorates UUO-induced renal fibrosis. Cell Death and Disease. 14(12). 818–818. 9 indexed citations
7.
Ma, Yiyi, Mingzi Zhang, Lili Fu, et al.. (2023). Automatic Segmentation of Kidney Volume Using Multi-Module Hybrid Based U-Shape in Polycystic Kidney Disease. IEEE Access. 11. 58113–58124. 6 indexed citations
8.
Li, Zhaoping, Minghao Zhang, Lulu Han, et al.. (2023). Counterintuitive relationship between the triglyceride glucose index and diabetic foot in diabetes patients: A cross-sectional study. PLoS ONE. 18(11). e0293872–e0293872. 3 indexed citations
9.
Wang, Weidong, Lili Fu, Jun Liu, et al.. (2023). Relationship between Dialysate Bicarbonate Concentration and All-Cause Mortality in Hemodialysis Patients. Kidney & Blood Pressure Research. 48(1). 460–467. 1 indexed citations
11.
Chen, Lin, et al.. (2022). Sika Deer Facial Recognition Model Based on SE-ResNet. Computers, materials & continua/Computers, materials & continua (Print). 72(3). 6015–6027. 2 indexed citations
12.
Fu, Lili, et al.. (2022). Icariin attenuates renal interstitial fibrosis through G protein-coupled estrogen receptor in a UUO murine model.. PubMed. 14(3). 1567–1577. 7 indexed citations
13.
Gu, Xiangchen, et al.. (2017). KLF 15 Works as an Early Anti-Fibrotic Transcriptional Regulator in Ang II-Induced Renal Fibrosis via Down-Regulation of CTGF Expression. Kidney & Blood Pressure Research. 42(6). 999–1012. 17 indexed citations
14.
Chen, Gaozhi, Bing Xiao, Lingfeng Chen, et al.. (2017). Discovery of new MD2-targeted anti-inflammatory compounds for the treatment of sepsis and acute lung injury. European Journal of Medicinal Chemistry. 139. 726–740. 24 indexed citations
15.
Zhang, Yali, Zhiguo Feng, Tingting Xu, et al.. (2016). A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo. Drug Design Development and Therapy. Volume 10. 1947–1959. 12 indexed citations
16.
Wang, Guozhi, et al.. (2014). Recombinant tuberculosis vaccine AEC/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection. Journal of Microbiology Immunology and Infection. 48(6). 597–603. 39 indexed citations
17.
Liu, Chunyan, Yi Zhang, Li Yuan, Lili Fu, & Changlin Mei. (2013). Rosiglitazone inhibits insulin-like growth factor-1-induced polycystic kidney disease cell growth and p70S6 kinase activation. Molecular Medicine Reports. 8(3). 861–864. 18 indexed citations
18.
Gao, Xiang, Lianghu Huang, Fabrizio Grosjean, et al.. (2011). Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15. Kidney International. 79(9). 987–996. 60 indexed citations
19.
Zhang, Miao, Xiang Gao, Jianxiang Wu, et al.. (2010). Oxidized high‐density lipoprotein enhances inflammatory activity in rat mesangial cells. Diabetes/Metabolism Research and Reviews. 26(6). 455–463. 19 indexed citations
20.
Fu, Lili, Li Wang, Lin Li, et al.. (2008). Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo. Investigational New Drugs. 27(1). 1–11. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026